Clinical Trial Update: IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating IV plerixafor with mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Etoposide (Etoposide)
• Mitoxantrone (mitoxantrone)
• Plerixafor (Plerixafor)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Leukemia, Myeloid, Acute | Phase 1 | Status: TERMINATED